Andrew Bellinger - Oct 28, 2022 Form 4 Insider Report for Verve Therapeutics, Inc. (VERV)

Role
CSO & CMO
Signature
/s/ Andrew Ashe, Attorney-in-Fact for Andrew Bellinger
Stock symbol
VERV
Transactions as of
Oct 28, 2022
Transactions value $
-$384,200
Form type
4
Date filed
11/1/2022, 05:00 PM
Previous filing
Sep 27, 2022
Next filing
Dec 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERV Common Stock Options Exercise $14.8K +10K +150.85% $1.48* 16.6K Oct 28, 2022 Direct
transaction VERV Common Stock Sale -$399K -10K -60.14% $39.90 6.63K Oct 28, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERV Stock Option (right to buy) Options Exercise $0 -10K -10.31% $0.00 87K Oct 28, 2022 Common Stock 10K $1.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2022.
F2 The remaining shares underlying this option, which was granted on September 17, 2019, vest in equal monthly installments until October 1, 2023.